GT Biopharma, Inc.
- GTBP
- NASDAQ
- Biotechnology
- Immuno-Oncology
- TriKE Fusion Proteins
$7.03
Today −4.48%Quote Oct 16, 2026, 08:00 PM UTC
−6.14%over the last month
Max drawdown −20.4%From 1-month high −6.1%3 months −17.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$317.1M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$6.97
0.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GTBPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
1
Founded
1965